The decrease in RSPO3 mRNA expression with advancing liver disease was confirmed by bulk RNA-seq analysis in additional MASLD cohorts (Fig. 5j and Extended Data Fig. 12a). This evidence concerns the gene RSPO3 and liver disorder.